Vitamin D status and incidence of pulmonary tuberculosis, opportunistic infections, and wasting among HIV-infected tanzanian adults initiating antiretroviral therapy

Journal of Infectious Diseases

Volumn 207, Issue 3, 2013, Pages 378-385

  Sudfeld, Christopher R ^a   Giovannucci, Edward L ^a,b   Isanaka, Sheila ^a   Aboud, Said ^c   Mugusi, Ferdinand M ^c   Wang, Molin ^a   Chalamilla, Guerino ^d   Fawzi, Wafaie W ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^d MANAGEMENT AND DEVELOPMENT FOR HEALTH   (Tanzania)

Author keywords

ART; HIV; malaria; micronutrient; morbidity; pneumonia; tuberculosis; Vitamin D; wasting

Indexed keywords

25 HYDROXYVITAMIN D; ALPHA TOCOPHEROL; ANTIRETROVIRUS AGENT; ASCORBIC ACID; EFAVIRENZ; NEVIRAPINE; STAVUDINE; VITAMIN B COMPLEX; ZIDOVUDINE; COTRIMOXAZOLE; LAMIVUDINE;

ADULT; ANEMIA; ARTICLE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION RISK; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALARIA; MALE; NUTRITIONAL STATUS; OBSERVATIONAL STUDY; OPPORTUNISTIC INFECTION; PNEUMONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; TANZANIA; THRUSH; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; WASTING SYNDROME; WEIGHT REDUCTION; LONGITUDINAL STUDY; VITAMIN SUPPLEMENTATION;

ADULT; AGED; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COHORT STUDIES; FEMALE; HIV INFECTIONS; HIV WASTING SYNDROME; HUMANS; INCIDENCE; MALE; MIDDLE AGED; OPPORTUNISTIC INFECTIONS; PROPORTIONAL HAZARDS MODELS; TANZANIA; TUBERCULOSIS, PULMONARY; VITAMIN D; YOUNG ADULT;

EID: 84872049622     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis693     Document Type: Article

References (51)

1. Andersson J, Fehniger TE, Patterson BK, et al. Early reduction of immune activation in lymphoid tissue following highly active HIV therapy. AIDS 1998; 12:F123-9.
2. Autran B, Carcelain G, Li TS, et al. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science 1997; 277:112-6.
3. Lawn SD, Little F, Bekker LG, et al. Changing mortality risk associated with CD4 cell response to antiretroviral therapy in South Africa. AIDS 2009; 23:335-42.
4. Lawn SD, Myer L, Edwards D, Bekker LG, Wood R. Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa. AIDS 2009; 23: 1717-25.
5. Deluca HF, Cantorna MT. Vitamin D: its role and uses in immunology. FASEB J 2001; 15:2579-85.
6. Kamen DL, Tangpricha V. Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity. J Mol Med 2010; 88:441-50.
7. Sudfeld CR, Wang M, Aboud S, Giovannucci EL, Mugusi FM, Fawzi WW. Vitamin D and HIV progression among a Tanzanian adults initiating antiretroviral therapy. PLoS One 2012; 7:e40036.
8. Mehta S, Mugusi FM, Spiegelman D, et al. Vitamin D status and its association with morbidity including wasting and opportunistic illnesses in HIV-infected women in Tanzania. AIDS Patient Care STDS 2011; 25:579-85.
9. Davies PD, Church HA, Brown RC, Woodhead JS. Raised serum calcium in tuberculosis patients in Africa. Eur J Respir Dis 1987; 71:341-4.
10. Davies PDO, Church HA, Bovornkitti S, Charumilind A, Byrachandra S. Altered vitamin D homeostasis in tuberculosis. Int Med Thailand 1988; 4:45-7.
11. Wilkinson RJ, Llewelyn M, Toossi Z, et al. Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: A case-control study. Lancet 2000; 355:618-21.
12. Sasidharan PK, Rajeev E, Vijayakumari V. Tuberculosis and vitamin D deficiency. J Assoc Physicians India 2002; 50:554-8.
13. Sita-Lumsden A, Lapthorn G, Swaminathan R, Milburn HJ. Reactivation of tuberculosis and vitamin D deficiency: The contribution of diet and exposure to sunlight. Thorax 2007; 62:1003-7.
14. Gibney KB, MacGregor L, Leder K, et al. Vitamin D deficiency is associated with tuberculosis and latent tuberculosis infection in immigrants from sub-Saharan Africa. Clin Infect Dis 2008; 46:443-6.
15. Vanham G, Edmonds K, Qing L, et al. Generalized immune activation in pulmonary tuberculosis: co-activation with HIV infection. Clin Exp Immunol. 1996; 103:30-4.
16. Talat N, Perry S, Parsonnet J, et al. Vitamin D deficiency and tuberculosis progression. Emerg Infect Dis 2010; 16:853-5.
17. Ganmaa D, Giovanncci E, Bloom BR, et al. Vitamin D, tuberculin skin test conversion and latent tuberculosis in Mongolian school-age children: a randomized, double-blind, placebo controlled feasibility trial. Am J Clin Nutr 2012; 96:391-6.
18. Isanaka S, Mugusi FM, Hawkins C, et al. High-dose multivitamin supplementation at the initiation of highly active anti-retroviral therapy: a randomized controlled trial in Tanzania. JAMA 2012; 308:1535-44.
19. World Health Organization. Scaling up antiretroviral therapy in resource-limited settings: treatment guidelines for a public health approach. Geneva: World Health Organization, 2004.
20. Lensmeyer GL, Wiebe DA, Binkley N, Drezner MK. HPLC method for 25-hydroxyvitamin D measurement: comparison with contemporary assays. Clin Chem 2006; 52:1120-6.
21. Enarson DA, Rieder HL, Arnadottir T. Tuberculosis guide for low income countries. 3rd ed. Paris: International Union Against Tuberculosis and Lung Disease, 1994:1-64.
22. World Health Organization Expert Committee. Physical status: the use and interpretation of anthropometry. WHO technical report series
23. Geneva: World Health Organization, 1995.
24. Polsky B, Kotler D, Steinhart C. HIV-associated wasting in the HAART era: Guidelines for assessment, diagnosis, and treatment. AIDS Patient Care STDs 2001; 15:411-23.
25. World Health Organization. Nutritional anaemias. Report of a WHO Scientific Group. WHO technical report series 405. Geneva: World Health Organization, 1968:9-10.
26. Massawe SN, Urassa EN, Nyström L, Lindmark G. Effectiveness of primary level antenatal care in decreasing anemia at term in Tanzania. Acta Obstet Gynecol Scand 1999; 78:573-9.
27. Heaney RP. Functional indices of vitamin D status and ramifications of vitamin D deficiency. Am J Clin Nutr 2004; 80:1706S-9S.
28. Institute of Medicine. Dietary reference intakes for calcium and vitamin D. Washington, DC: The National Academies Press, 2011.
29. Cox D. Regression models and life tables. J Royal Stat Soc 1972; 34: 187-220.
30. Hansen KE, Jones AN, Lindstrom MJ, Davis LA, Engelke JA, Shafer MM. Vitamin D insufficiency: disease or no disease? J Bone Miner Res 2008; 23:1052-60.
31. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357:266-81.
32. Durrleman S, Simon R. Flexible regression models with cubic splines. Stat Med 1989; 8:551-61.
33. Govindarajulu US, Spiegelman D, Thurston SW, Ganguli B, Eisen EA. Comparing smoothing techniques in Cox models for exposure-response relationships. Stat Med 2007; 26:3735-52.
34. Diggle PJ, Heagerty P, Liang KY, Zeger SL. Analysis of longitudinal data. 2nd ed. Oxford, England: Oxford University Press, 2002.
35. Fabri M, Stenger S, Shin DM, et al. Vitamin D is required for IFN-{gamma}-mediated antimicrobial activity of human macrophages. Sci Transl Med 2011; 3:104ra102.
36. Liu PT, Stenger S, Li H, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006; 311:1773-3.
37. Gombart AF, Borregaard N, Koeffler HP. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1, 25-dihydroxyvitamin D3. FASEB J 2005; 19:1067-77.
38. Sly LM, Lopez M, Nauseef WM, Reiner NE. 1 alpha, 25-dihydroxyvitamin D3-induced monocyte antimycobacterial activity is regulated by phosphatidylinositol 3-kinase and mediated by the NADPHdependent phagocyte oxidase. J Biol Chem 2001; 276:35482-93.
39. Anand K, Kaul D. Vitamin D3-dependent pathway regulates TACO gene transcription. Biochem Biophys Res Commun 2003; 10:876-7.
40. Coussens A, Timms PM, Boucher BJ, et al. 1alpha, 25-dihydroxyvitamin D3 inhibits matrix metalloproteinases induced by Mycobacterium tuberculosis infection. Immunology 2009; 127:539-48.
41. Weight loss and survival in HIV-positive patients in the era of highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2002; 31:230-6.
42. Madec Y, Szumilin E, Genevier C, et al. Weight gain at 3 months of antiretroviral therapy is strongly associated with survival: evidence from two developing countries. AIDS 2009; 27:853-61.
43. Rimaniol AC, Zylberberg H, Zavala F, Viard JP. Inflammatory cytokines and inhibitors in HIV infection: Correlation between interleukin-1 receptor antagonist and weight loss. AIDS 1996; 10: 1349-56.
44. Wanke CA, Silva M, Ganda A, et al. Role of acquired immune deficiency syndrome-defining conditions in human immunodeficiency virus-associated wasting. Clin Infect Dis 2003; 37:S81-4.
45. Villamor E, Saathoff E, Mugusi F, Bosch RJ, Urassa W, Fawzi WW. Wasting and body composition of adults with pulmonary tuberculosis in relation to HIV-1 coinfection, socioeconomic status, and severity of tuberculosis. Eur J Clin Nutr 2006; 60:163-71.
46. Mehta S, Giovanucci E, Mugusi FM, et al. Vitamin D status of HIVinfected women and its association with HIV disease progression, anemia, and mortality. PLoS One 2010; 5:e8770.
47. Meguro S, Tomita M, Katsuki T, et al. Plasma 25-hydroxyvitamin D is independently associated with hemoglobin concentration in male subjects with type 2 diabetes mellitus. Int J Endocrinol 2011; 2001: 362981.
48. Getahun H, Harrington M, O'Brien R, Nunn P. Diagnosis of smearnegative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes. Lancet 2007; 369:2042-9.
49. Allavena C, Delpierre C, Cuzin L, et al. High frequency of vitamin D deficiency in HIV-infected patients: effects of HIV-related factors and antiretroviral drugs. J Antimicrob Chemother 2012; 67:2222-30.
50. Fox J, Peters B, Prakash M, Arribas J, Hill A, Moecklinghoff C. Improvement in vitamin D deficiency following antiretroviral regime change: results from the MONET trial. AIDS Res Hum Retroviruses 2011; 27:29-34.
51. Horsburgh CR. Priorities for the treatment of latent tuberculosis infection in the United States. N Engl J Med 2004; 350:2060-7.